NAP3: Major Complications of Central Neuraxial Block in the United Kingdom

NAP3 Overview

Central neuraxial blocks (CNB) involve the injection of pain-relieving drugs into the spinal canal. CNB has the potential to provide patients with optimal pain relief, but can also lead to patient harm.

The number of CNB performed in the UK was previously unknown, as was the frequency with which CNB leads to patient harm.

NAP3 was designed to answer the questions:

  • What types of CNB are used in the UK, and how often?
  • How often do major complications, leading to permanent harm, occur in association with CNB?
  • What happens to the patients experiencing these complications?

 

What were the findings?

Please click below to download the NAP3 Report, or sections of the NAP3 Report.

NAP3 Report

Major Complications of Central Neuraxial Block in the United Kingdom

NAP3 Report Section 1

Project description and quantitative analysis

NAP3 Report Section 2

Clinical reviews

Return to the National Audit Projects home page